Dennis Podlesak's Net Worth

$3.59 Million

Estimate Recalculated Feb 9, 2024 04:13PM EST

Who is Dennis Podlesak?

Dennis Podlesak has an estimated net worth of $3.59 Million. This is based on reported shares across multiple companies, which include Alliqua BioMedical, Inc., Syndax Pharmaceuticals Inc, AVANIR PHARMACEUTICALS, INC., Regado Biosciences Inc, and DOV PHARMACEUTICAL INC.

SEC CIK

Dennis Podlesak's CIK is 0001314595

Past Insider Trading and Trends

2006 was Dennis Podlesak's most active year for acquiring shares with 4 total transactions. Dennis Podlesak's most active month to acquire stocks was the month of January. 2022 was Dennis Podlesak's most active year for disposing of shares, totalling 6 transactions. Dennis Podlesak's most active month to dispose stocks was the month of August. 2022 saw Dennis Podlesak paying a total of $498,307.48 for 110,815 shares, this is the most they've acquired in one year. In 2022 Dennis Podlesak cashed out on 157,630 shares for a total of $1,897,987.53, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Alliqua BioMedical, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
85.25K
—
—
85.25K
May 3
Form 3
—
0
—
—
0
No matching records found

Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.25

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+31.55%
34K
—
—
141.76K
Feb 7
Form 4
+42.24%
32K
—
—
107.76K
Feb 2
Form 4
—
0
$15.20
-$1,399,680.05
75.76K
Scheduled
Sep 15 - Sep 16
Form 4
+73.12%
32K
—
—
75.76K
Feb 2
Form 4
+1.07%
463
—
—
43.76K
Oct 5
Form 4
+47.62%
13.97K
$14.11
$197,077.16
43.3K
Apr 22
Form 4
∞
29.33K
—
—
29.33K
Feb 3
Form 4
—
0
—
—
0
Feb 12
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
May 23
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
May 17
Form 4
—
0
—
—
0
Oct 31
Form 3
—
0
—
—
0
No matching records found

AVANIR PHARMACEUTICALS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+9.40%
28.9K
—
—
336.39K
Feb 12
Form 4
+14.48%
38.9K
—
—
307.49K
Feb 14
Form 4
+12.57%
30K
—
—
268.59K
Feb 16
Form 4
+14.38%
30K
—
—
238.59K
Feb 8
Form 4
+23.73%
40K
—
—
208.59K
Feb 18
Form 4
+55.25%
60K
—
—
168.59K
Feb 19
Form 4
+110.12%
56.91K
—
—
108.59K
Feb 21
Form 4
+595.13%
44.25K
—
—
51.68K
Mar 1
Form 4
+15.54%
1K
$9.90
$9,902.00
7.43K
May 31
Form 4
∞
6.43K
—
—
6.43K
Feb 13
Form 3
—
0
—
—
0
No matching records found

Regado Biosciences Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

DOV PHARMACEUTICAL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
Aug 9
Form 4
∞
8.33K
—
—
8.33K
May 22
Form 3
—
0
—
—
0
No matching records found